Daewoong Pharmaceutical Shares Key Data from Phase 2 IPF Drug Trial at ERS 2026 #South_Korea #Seoul #IPF #Daewoong #Bersiporocin

Daewoong Pharmaceutical Unveils Comprehensive Data on 104 IPF Patients at ERS 2026 Conference #South_Korea #Seoul #Daewoong #Bersiporocin #IPF_Drug

Daewoong Pharmaceutical Shares Groundbreaking Baseline Data from Global Phase 2 Trial of Bersiporocin for IPF #South_Korea #Seoul #IPF #Bersiporocin #Daewoong_Pharmaceutical